A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder
Clinical trial NCT01103362 · TERMINATED
Trial details
- NCT number
- NCT01103362
- Sponsor
- Sprout Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-01-01
- Enrollment
- 596
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.